Cell Therapies gains first T-Cell GMP manufacturing licence in Australia
The licence allows for the collection, manufacturing, testing, storage and release for the supply of any commercial T-Cell product
Breaking News
Research: Commercial cannabidiol on the UK market is illegal
Consumer products are contaminated with impurities, exceed legal limits of psychoactive cannabinoids and CBD content ...
FDA approves two generic injectables from Novadoz Pharmaceuticals
The Hyderabad, India-based affiliate of Novadoz, MSN Labs, has received approval for Decitabine and Fosaprepitant and ...
Europe releases 10th Pharmacopoeia edition with 114 new monographs
Thoroughly revised general chapters include infrared absorption spectrophotometry and Ultraviolet & visible absorption ...
Managing regulatory labelling challenges in the medical device sector
Wherever they are in the healthcare supply chain, a unique device identification (UDI) system for medical devices is ...
Mile High Labs gains ISO 9001:2015 certifications
The hemp-derived CBD processor reaffirms previous Good Manufacturing Practice audits
Bora secures FDA approval for CDMO services
The Taiwanese oral solid drugmaker specialises in modified release (MR) and solvent production
The future of supply chain management in pharmaceuticals
Global regulations and local legislation have made serialisation in the pharmaceutical industry standard practice. And, ...
NSF Responsible Person Course gains MHRA recognition and Cogent Gold Standard
The Responsible Person (import) is required to implement a system for confirming QP certification has taken place when ...
Women’s Equality Day: Pharma is levelling the playing field
Barbara Morgan, Pharmaceutical Business Director at Lubrizol Life Science Health, reflects on the issue of gender ...
A rules-based approach to labelling and artwork management: Part II
A business rules engine can bring a level of simplification to what is becoming an increasingly sophisticated activity, ...
Review: Cannabis Europa 2019
Scientists, businesspeople and politicians backing the regulation of medical and recreational cannabis have taken the ...
The power of real-world patient data
Real-world data has the potential to vastly improve the effectiveness and efficiency of the drug development pipeline, ...
Biocon recieves GMP status for Malaysian insulin facility
Indian Biocon’s Malaysia facility manufactures drug substance and drug products in vials, cartridges and insulin ...
ABPI: Tackling vaccine hesitancy should be a priority
The Association of the British Pharmaceutical Industry responds to the UK's commitment to improving declining ...
In Brief
Most Popular in Regulatory
- Research: Commercial cannabidiol on the UK market is illegal
- The rising importance of preservative efficacy testing
- Cell Therapies gains first T-Cell GMP manufacturing licence in Australia
- Pharmaceutical method development and validation
- Managing regulatory labelling challenges in the medical device sector
Featured Companies
Reports
